Acuired by Amgen 10/3/23. Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives. Show more
Location: | Website: www.horizontherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$116.30
Open
$116.30
Volume
N/A
Day Range
$116.30 - $116.30
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
1.18%
Institutional Own.
-
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|